Evidence also showed midbrain dopamine neurons expressed its preferred receptor GFRα4 [15], indicating the possible neurotrophic effect of PSPN on dopaminergic neurons via GFRα4 in PD. The gene discussed is PSPN; the disease is Parkinson disease.